Repurposing the anti-hypertensive agent Aliskiren into an anti-diabetic agent:  Aliskiren (brand name: Tekturna and Rasilez), an antihypertensive agent, increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of  its target gene Lin28, 26/October, 2018, 12.15 am